Sun Pharma boss and ex-Teva CEO shine light into Israeli life science investor Bio-Light
This article was originally published in Scrip
It's not every day that you hear of Teva Pharmaceutical Industries' ex-CEO, Israel Makov, and Sun Pharma's founder chairman and managing director, Dilip Shanghvi, becoming co-investors in a life science technology investment firm.
You may also be interested in...
Cipla has outlined its intent to incubate disruptive ideas in the healthcare space, along the lines of similar initiatives to accelerate innovation from US/European big pharma. It hopes that this "culture" will expand in India.
Aurobindo and Sandoz mutually terminate their planned $1bn deal, leaving many questions on how both sides will re-orient strategies going forward.
Takeda appoints new country head for India and aims to improve patient access to innovative medicines in the largely out-of-pocket market.